Praxis Precision Medicines (PRAX) Interest Expenses (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Interest Expenses of $454.1 million for Q1 2026, up 40551.3% year-over-year from N/an in Q1 2025, and up 10.77% quarter-over-quarter from $409.9 million in Q4 2025.
Praxis Precision Medicines (PRAX) Interest Expenses (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Interest Expenses history runs 8 years deep, the most recent figure standing at $454.1 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 40551.3% year-over-year to $454.1 million; the TTM figure through Mar 2026 stood at $454.1 million (up 40551.3% YoY), while the FY2025 annual figure was $409.9 million, up 87.78% from the prior year.
- Interest Expenses for Q1 2026 stood at $454.1 million, up from $409.9 million in the prior quarter.
- The five-year high for Interest Expenses was $454.1 million in Q1 2026, with the low at $23000.0 in Q1 2023.
- The 5-year median for Interest Expenses is $8.7 million (2025), against an average of $86.0 million.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses plunged 99.84% in 2023, then jumped 61626.09% in 2024.
- Praxis Precision Medicines' Interest Expenses stood at $143.9 million in 2022, then gained by 25.41% to $180.5 million in 2023, then advanced by 20.94% to $218.3 million in 2024, then soared by 87.78% to $409.9 million in 2025, then advanced by 10.77% to $454.1 million in 2026.
- Business Quant data shows PRAX's Interest Expenses at $454.1 million in Q1 2026, $409.9 million in Q4 2025, and $8.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | 466.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 466.14 Mn |
| Jun 30, 2026 | 466.14 Mn |
| Mar 31, 2026 | 454.08 Mn |
| Mar 31, 2026 | 454.08 Mn |
| Dec 31, 2025 | 409.94 Mn |
| Dec 31, 2025 | 409.94 Mn |
| Sep 30, 2025 | 8.66 Mn |
| Sep 30, 2025 | 8.66 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 218.30 Mn |
| Dec 31, 2024 | 218.30 Mn |
| Sep 30, 2024 | 12.80 Mn |
| Sep 30, 2024 | 12.80 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 14.20 Mn |
| Mar 31, 2024 | 14.20 Mn |